April 18, 2018

Humalutin Inhibits Tumor Growth in Non-Hodgkin’s Lymphoma, Preclinical Study Shows

News

Humalutin (177Lu-NNV003), a novel tumor-targeting antibody labeled with radiation, demonstrated promising results in animal models of non-Hodgkin’s lymphoma (NHL), Nordic Nanovector announced. Humalutin is an investigational, humanized version of Betalutin — Nordic’s lead therapy candidate ... Read more

December 6, 2017December 6, 2017

TRPH-222 Shows Significant Anti-tumor Activity in Lymphoma Preclinical Models

News

An investigational antibody-drug conjugate, TRPH-222, effectively reduced tumor burden in mice with diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL), and is well-tolerated in non-human primates, a new ... Read more